An RNA sequence of hundreds of nucleotides at the 5' end of poliovirus RNA is involved in allowing viral protein synthesis by Trono, Didier et al.
JOURNAL OF VIROLOGY, JUlY 1988, p. 2291-2299
0022-538X/88/072291-09$02.00/0
Copyright © 1988, American Society for Microbiology
An RNA Sequence of Hundreds of Nucleotides at the 5' End of
Poliovirus RNA Is Involved in Allowing Viral Protein Synthesis
DIDIER TRONO,1 RAUL ANDINO,1 AND DAVID BALTIMORE`.2*
Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142,1* and Department ofBiology,
Massachusetts Institute of Technology, Cambridge, Massachusetts 021392
Received 28 December 1987/Accepted 1 April 1988
Twenty-one mutations were engineered in the 5' noncoding region of poliovirus type 1 RNA, using an
infectious cDNA copy of the viral genome. RNA was made from these constructs and used to transfect HeLa
cells. Viable virus was recovered from 12 of these transfection experiments, including six strains with a
recognizable phenotype, mapping in four different regions. One mutant of each site was studied in more detail.
Mutant 5NC-11, having a 4-base insertion at nucleotide 70, was dramatically deficient in RNA synthesis,
suggesting that the far 5' end of the genome is pritnarily involved in one or more steps of RNA replication.
Mutants 5NC-13, 5NC-114, and 5NC-116, mapping at nucleotides 224, 270, and 392, respectively, showed a
similar behavior; they made very little viral protein, they did not inhibit host cell translation, and they
synthesized a significant amount of viral RNA, although with some delay compared with wild type. These three
mutants were efficiently complemented by all other poliovirus mutants tested, except those with lesions in
protein 2A. Our results imply that these three mutants map in a region (region P) primarily involved in viral
protein synthesis and that their inability to shut off host cell translation is secondary to a quantitative defect in
protein 2A. The exact function of region P is still to be determined, but our data supports the hypothesis of a
single functional module allowing viral protein synthesis and extending over several hundred nucleotides.
The genome of poliovirus is a single-stranded molecule of
mRNA polarity (positive strand) containing approximately
7,500 nucleotides. Its 5' end is linked to a small peptide,
VPg, and its 3' end is a stretch of poly(A) 40 to 100
nucleotides long. A total of more than 800 noncoding nucle-
otides are located at the two ends of poliovirus RNA, 742 at
its 5' end and 65 preceding the poly(A) at its 3' end (9, 18).
An open reading frame initiated by an AUG at position 743
(4) encompasses 6,528 nucleotides and encodes a polypro-
tein of about 250,000 daltons. Poliovirus mRNA, like that of
other picornaviruses, not only has an unusually long un-
translated 5' region, but also iE not capped at its 5' end. It
terminates in pUp instead of the "capping" group
m7G(5')ppp(5')N . . ., found on almost all other mRNAs (7,
16).
A highly significant sequence similarity extends through
the first 650 nucleotides of the three poliovirus serotypes
(26). This marked conservation strongly suggests that the 5'
terminal region serves crucial functions in the virus life
cycle. Several potential functions can be imagined for the 5'
noncoding (5NC) region, e.g., initiation of protein synthesis
(binding of ribosomes and initiation factors), initiation of
synthesis of plus-strand RNA, stabilization of the RNA by
secondary structure formation, interaction with the viral
capsid proteins during packaging of the RNA, or binding of
presumptive regulatory molecules that control the replica-
tion and translation of the viral RNA. The 5NC region
appears to have a critical role in neurovirulence. Neurovi-
rulent revertants of the Sabin type 3 strain have been
isolated from patients with vaccine-associated poliomyelitis;
compared with their attenuated parental strain, they were
found to have a single base substitution at position 472 of
the genome (6). Reinforcing this data, in vitro experiments
using recombinants between wild-type and attenuated
strains have confirmed that a major determinant of neurovi-
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rulence is located in the 5NC region of types 1 (15) and 3 (27)
poliovirus.
In an attempt to elucidate the functions of the 5NC region,
we have created a number of mutations in this part of
poliovirus type 1 (Mahoney) RNA. The mutations were
made by mutagenesis of an infectious cDNA clone (19) and
by the recovery of altered viral strains, as previously used by
us (2, 22) and others (10, 23) to study various aspects of
poliovirus molecular biology and genetics. With these muta-
tions, we have been able to delineate at least two functional
regions, one primarily involved in the synthesis of the viral
RNA, the other in its translation. This last function seems to
be accomplished by an extensive sequence of nucleotides,
suggesting the role of an RNA superstructure in the initiation
of translation. Mutants deficient in the translation function
also provide important information on the inhibition of host
mRNA translation in poliovirus-infected cells.
MATERIALS AND METHODS
DNA procedures. Restriction enzymes, T4 DNA polymer-
ase, and T4 DNA ligase were purchased from New England
BioLabs, Inc., Beverly, Mass.; DNA polymerase I (Klenow
fragment) was from Boehringer Mannheim Biochemicals,
Indianapolis, Ind.; exonuclease BAL 31 was from Interna-
tional Biotechnologies, Inc., New Haven, Conn.; T7 RNA
polymerase and human placenta RNase inhibitor was from
Promega Biotec, Madison, Wis.; and avian myeloblastosis
virus reverse transcriptase was from Life Sciences Re-
search, Baltimore, Md. All enzymes and compounds were
used according to the instructions of the manufacturer.
Mutagenesis was done on a pBR-based subclone contain-
ing the first 1,200 nucleotides of poliovirus type 1 (Mahoney)
cDNA, downstream of a T7 RNA polymerase promoter (a
modification of our original infectious clone) (19). The three
protocols used were filling in restriction sites (partial diges-
tion with a restriction enzyme, blunting with Klenow, liga-
tion), deleting restriction site overhangs (partial digestion,
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blunting with T4 DNA polymerase, ligation), and inserting
linkers at some restriction sites (partial digestion, blunting
with Klenow or T4 DNA polymerase, linker ligation). The
AatII site at position 1118 of poliovirus sequence was then
used to introduce all the mutated 5' ends into the full-length
clone. Mutations were confirmed by sequencing plasmids by
the chemical technique (13), and the derived viral RNA for
viable mutants was sequenced by primer extension (21). We
are confident that the alterations engineered into clones were
responsible for the mutant phenotypes because only the first
1,118 nucleotides were in the altered region and because a
number of the mutants were created independently twice
with the same phenotypic consequences.
Cells and viruses. HeLa and CV1 cells were grown as
previously described (2). HeLa cells on 100-mm-diameter
dishes were transfected with 2 to 5 ,ug of in vitro-synthesized
RNA, using the DEAE-dextran procedure (12). All con-
structs were also tested by DNA transfection (average 10 ,ug)
according to the same protocol. The generation of infectious
virus particles was checked by covering the transfected cells
with an agar overlay and examining the plates for plaques
over 2 to 5 days and also by harvesting cells that had been
transfected, treating them by three cycles of freeze and
thaw; and using them for a plaque assay on a new mono-
layer. Stocks from each viable virus were grown according
to standard techniques (2).
One-step growth curves. Measurement of virus growth and
release was done on 60-mm-diameter HeLa cells dishes,
according to standard procedures (2).
Measurement of viral RNA synthesis. Monolayer cultures
of HeLa cells were infected at a multiplicity of infection
(MOI) of 10, and after adsorption at room temperature for 30
min, Dulbecco modified Eagle medium (DME) supple-
mented with 7% fetal calf serum (Hazleton) was added. At
various times after infection, cells were placed on ice,
washed once with cold phosphate-buffered saline, and lysed
in 10 mM Tris hydrochloride (pH 7.5)-10 mM NaCI-0.1%
Nonidet P-40. Nuclei and debris were removed by centrifu-
gation. RNA was isolated by phenol-chloroform extraction
and ethanol precipitation. Portions were denatured in 1Ox
SSC (lx is 0.15 M NaCl, 15 mM sodium citrate)-17%
formaldehyde and bound to nitrocellulose by aspiration with
a dot-blot apparatus. Filters were baked for 2 h at 80°C under
vacuum, prehybridized in sealed bags at 37°C for 2 h in 50%
formamide-5x SSCPE (lx is lx SSC, 13 mM KH2PO4, 1
mM EDTA)-5x Denhardt solution-0. 1% sodium dodecyl
sulfate (SDS)-250 jig of herring sperm DNA per ml-500 ,ug
of yeast tRNA per ml; the filters were hybridized overnight
at 60°C in the same solution, using [32P]RNA probes gener-
ated with SP6 or T7 polymerase as described previously (14).
The probes represented nucleotides 670 to 2243 of the
poliovirus type 1 Mahoney genome, in either direction. After
hybridization, filters were washed in 0.2x SSC three times at
680C and exposed to X-ray film. Regions in which RNA was
bound were then cut out and dissolved in Biofluor (National
Diagnostics), and radioactivity was measured with a scintil-
lation counter.
Nucleotide sequencing of RNA. RNA from all viable vi-
ruses was prepared as above and was sequenced by the
chain-termination technique (21), using reverse transcriptase
and synthetic oligonucleotide primers complementary to
bases 120 to 143, 298 to 320, 477 to 500, and 758 to 781 of the
viral RNA.
Electrophoretic analysis of protein synthesis in infected
cells. Infection procedures were as described above. At
various times postinfection, cells were placed in methionine-
depleted Dulbecco modified Eagle medium containing 25
,uCi of [35S]methionine per ml. After 30 min of incubation,
cells were put on ice, washed once with cold phosphate-
buffered saline, harvested by centrifugation, and lysed in 10
mM Tris hydrochloride (pH 7.5)-10 mM NaCI-0.5% Nonidet
P-40. Nuclei were removed by centrifugation, and a portion
of the cytoplasmic extract was fractionated by electropho-
resis through a 12.5% SDS-polyacrylamide gel. After elec-
trophoresis, gels were treated with Autofluor (National
Diagnostics), dried, and exposed to X-ray film at -70°C.
Immunoprecipitation of infected cell extracts. [35S]methio-
nine-labeled cell extracts were immunoprecipitated in IPB
(20 mM Tris hydrochloride [pH 7.5], 1% Triton X-100, 0.5%
sodium deoxycholate, 0.1% SDS, 0.5 M NaCl, 1 mM
EDTA), by using a rabbit polyclonal poliovirus type 1
antivirion antiserum. After incubation for 1 h on ice, the
immune complexes were recovered by the addition of a 10%
solution of Staphylococcus aureus; the complexes were
washed three times with IPB, suspended in Laemmli sample
buffer (11), boiled, and centrifuged to remove the S. aureus
cells. The supernatants were analyzed by electrophoresis as
described above.
Immunoblot analysis of p220. Cytoplasmic extracts were
prepared as described above, and an immunoblot analysis
was performed as described by Bonneau and Sonenberg (3),
using a rabbit anti-p220 polyclonal antiserum (a gift from I.
Edery, McGill University, Montreal, Quebec, Canada).
Complementation experiments. HeLa or CV1 cell infec-
tions were performed at 39°C in 60-mm-diameter petri
dishes, and yields of progeny virus were measured at various
times, as described by Bernstein et al. (1). The complemen-
tation index (CI) was defined as follows: CI for mutant A =
(titer of mutant A in mixed infection)/(titer of mutant A in
single infection), where titers are measured at the permissive
temperature. Results for revertants and recombinants, iden-
tified by the size of plaques and by the loss of temperature
sensitivity, were subtracted from the counts.
RESULTS
Mutagenesis. Not knowing which area of the 5NC region
might be critical to a given function, we randomly mutagen-
ized the whole region by insertion or deletion of multiple
nucleotides at various convenient sites (see Materials and
Methods). Some sites were modified in several ways, some-
times with different results, as will be outlined below. After
the mutations were engineered into subclone pL1.4, they
were introduced into the full-length clone pXpA, generating
constructs pPN-1 to pPN-21. These constructs and their
locations are described in Table 1 and Fig. 1. Using T7 RNA
polymerase, RNA was made from all the constructs and
used to transfect HeLa cells, and the recovery of infectious
virus particles was tested by plaque assay on HeLa cells.
Three kinds of results were seen (Fig. 1).
First, nine mutations involving seven sites (those in pPN-
1, -2, -9, -12, and -16 to -20) were lethal, meaning that no
infectious virus particle was recovered from the transfected
cells.
Second, five mutations at three different restriction sites
(in pPN-5, -6, -7, -10, and -13) did not affect the phenotype of
the virus, at least as assessed by plaque assay. Another
construct, pPN-21, with a deletion of bases 630 to 723,
generated by the sequential use of the BalI restriction
enzyme and BAL 31 exonuclease, also gave rise to virus
with a wild-type phenotype. Such a result has also been
reported with the Sabin type 1 strain, in which viruses
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FIG. 1. The result obtained from transfection of HeLa cells with
RNA made from the 21 mutated clones is shown. Numbers on top of
each arrow correspond to the constructs described in Table 1 (i.e.,
1 is pPN-1). Construct pPN-21 has a deletion of the sequence
indicated on the bottom line. Short arrows indicate lethal mutations
(D), medium-length arrows denote silent mutations (WT), and long
arrows point to mutations responsible for a recognizable viable
phenotype (M). Names of the mutant viruses are shown at the top of
the figure. Numbers on bottom lines indicate the nucleotide posi-
tions of the mutations.
lacking the genome region between nucleotides 600 and 726
are fully viable (10).
The third type of result was obtained from six mutations,
affecting four sites, all of which generated infectious viruses
with a phenotype easily distinguishable from that of the wild
type.
(i) Mutants 5NC-11 and 5NC-111. Deleting bases 67 to 70
by eliminating the free overhang of a KpnI site was found to
be lethal (pPN-2); however, duplicating the same four bases
by filling in the overhang left by its isoschizomer, BanI
(pPN-3), generated mutant 5NC-11. The further addition of
an EcoRI linker at this filled-in site (pPN-4) created mutant
5NC-111. Both mutants generate minute plaques compared
with those of wild-type virus and are temperature sensitive
(the titer at 32°C is 200-fold greater than the titer at 39°C).
(ii) Mutant 5NC-13. The insertion of 4 bases at position
224, taking advantage of a BamHI site (pPN-8), gave rise to
mutant 5NC-13. 5NC-13 is temperature sensitive (titer at
32°C is 100-fold greater than the titer at 39°C); moreover, the
sizes of the plaques it generates at both temperatures are
smaller than those of wild-type virus.
(iii) Mutant 5NC-114. The Hinfl site at position 267 could
be filled in without effect on the phenotype of the virus
(pPN-10); the further insertion of an 8-base linker (pPN-11)
generated mutant 5NC-114. 5NC-114 is slightly temperature
sensitive (5- to 10-fold) and has a small-plaque phenotype.
(iv) Mutants 5NC-116 and -1116. The insertion of 4 bases at
position 392 by filling in a NcoI site (pPN-13) did not
significantly affect the size of viral plaques; when the same
site was further modified by the introduction of a linker
(pPN-14) and when this linker was moreover blunted (pPN-
15), mutants 5NC-116 and 5NC-1116, respectively, were
obtained. Both mutants show a phenotype that resembles
the one of 5NC-114 in temperature sensitivity and plaque
size.
Assuming that slightly different modifications of the same
site would alter the same function, 5NC-111 and 5NC-1116
were not further characterized. Being only slightly temper-
ature sensitive, 5NC-114 and 5NC-116 were studied at 37°C.
One-step growth curves. To characterize the defects in the
four phenotypically mutant viruses, we examined some
basic parameters of the poliovirus life cycle. One-step
growth curves (Fig. 2) show that under nonpermissive con-
ditions, all of these mutants replicate more slowly than the
wild-type parental strain and produce a final progeny yield
that is lower.
Viral RNA synthesis. As a first step toward defining why
their replication was inefficient, we assessed the ability of
the 5NC mutants to synthesize RNA. This is usually done by
measuring the incorporation of [3H]uridine into viral RNA in
the presence of actinomycin D, a specific inhibitor of cellular
transcription. However, we found that the replication of all
of our 5NC mutants was sensitive to actinomycin D, in
contrast to wild-type virus (data not shown). The reason for
this sensitivity to actinomycin D is unknown but has been
reported in other mutants that map in the 5NC region (20) or
elsewhere (M. Girard, personal communication). We there-
fore analyzed viral RNA synthesis by dot blot, as described
TABLE 1. Mutagenesis
Clone Wild-type sequence Mutant sequence Phenotypea
pPN-1 AGT-52-ACT AGT-52-CCCCGGGACT D
pPN-2 G-66-GTACC G-66-,C D
pPN-3 GGTAC-70-C GGTAC-70-GTACC M (5NC-11)
pPN-4 GGTAC-70-C GGTAC-70-GGAAITCCGTACC M (5NC-111)
pPN-5 CTTA-108-G CTTA-108-HTAG WT
pPN-6 CTTA-108-G CTTA-108-GGAATTCCTTAG WT
pPN-7 CTTA-108-G CTTA-108-GGAATTAATTCCTTAG WT
pPN-8 GGATC-224-C GGATC-224-GATCC M (SNC-13)
pPN-9 GGATC-224-C GGATC-224-GGAATTCCGATCC D
pPN-10 GAAT-270-C GAAT-270-AATC WT
pPN-11 GAAT-270-C GAAT-270-GGAATTCCAATC M (5NC-114)
pPN-12 GAGT-325-C GAGT-325-AGTC D
pPN-13 CCATG-392-G CCATG-392-CATGG WT
pPN-14 CCATG-392-G CCATG-392-GGAATTCCCATGG M (SNC-116)
pPN-15 CCATG-392-G CCATG-392-GGAATTAATTCCCATGG M (SNC-1116)
pPN-16 GAAT-443-C GAAT-443-GGAATTCCAATC D
pPN-17 GAATG-460-CGGC GAATG-460-,GC D
pPN-18 GAATG-460-CGGC GAAT-460-..GGATTCCGC D
pPN-19 CAG-499-TGATTG CAG-499-,TTG D
pPN-20 CAG-499-TGATTG CAG-499-....GGAATTCCTTG D
a D, Dead (lethal mutation); WT, wild type (silent mutation); M, mutant.
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FIG. 2. One-step growth curve of 5NC mutants. Infection was done on HeLa cell monolayers as described in Materials and Methods.
Virus released into the medium and total virus production was determined at each time point. (Top) 5NC-13 at 32.5°C (left) and 39.50C (right);
(bottom) 5NC-114 at 37°C. Similar patterns were obtained from 5NC-11 and 5NC-116 (data not shown).
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in Materials and Methods (Fig. 3; only the result for positive-
strand RNA is shown, because the ratio of positive- to
negative-strand RNA was indistinguishable from that of wild
type with all mutants). 5NC-11 differed strikingly from
5NC-13, 5NC-114, and 5NC-116 with regard to viral RNA
synthesis; at both 32 and 39°C, 5NC-11 made less than 1% of
the wild-type amount of RNA (Fig. 3A). Further work is
under way to define which step ofRNA synthesis is affected
in this mutant; therefore, 5NC-11 will not be further de-
scribed here.
5NC-13, 5NC-114, and 5NC-116 behaved grossly similarly
regarding RNA synthesis, they made 30 to 60% of the
wild-type level of RNA, both plus and minus strand (Fig. 3B
and C). There was, however, a delay in RNA synthesis by all
of the mutants; for instance, at 37°C, wild-type RNA syn-
thesis peaked at 4 h postinfection, whereas 5NC-114 and
5NC-116 reached their maximal amounts of RNA synthesis
at 6 h postinfection. Although the three mutants are some-
what defective in RNA synthesis, this is not their primary
defect. A comparison of progeny virion yield and RNA
synthesis makes this point (Fig. 3D). 5NC-114 (and the
others similarly) made, at 6 h postinfection, about 50% of the
normal yield of RNA, with a normal ratio of single- to
double-stranded RNA (data not shown), but produced only
0.3% of the normal yield of progeny.
Protein synthesis in infected cells. To examine what might
be the primary defect in these mutants, we analyzed the
pattern of viral and cellular proteins synthesized in infected
cells. For this analysis, cells were pulse labeled with
[35S]methionine at various times after infection and cytoplas-
mic extracts were fractionated by electrophoresis through
SDS-polyacrylamide gels. In striking contrast to wild-type
virus, 5NC-13 (at 39°C), 5NC-114, and 5NC-116 did not shut
off host cell translation, even late after infection (Fig. 4A and
B). This failure to induce shutoff could be partly relieved by
increasing the MOI, as shown with 5NC-114 (Fig. 4C). To
resolve the virus-specific proteins that were made, we im-
munoprecipitated the extracts with antiviral antibodies that
reacted with the capsid proteins (Fig. 5). In all three mu-
tants, virus-specific protein synthesis was markedly de-
creased compared with that of wild type, detectable levels
appearing only several hours after infection. The processing
of the virion proteins appeared, however, to be normal, and
no excess of precursor accumulated at any point.
Fate of p220. Shutoff of host cell translation correlates
with the cleavage of one of the components of the cap-
binding complex, eucaryotic initiation factor 4F, also called
p220 (2, 5; for a review, see reference 24). To examine
whether our mutants failed to induce this cleavage, we
performed an immunoblot analysis of infected cell cytoplas-
mic extracts, using a polyclonal anti-p220 antibody (Fig. 6).
In wild-type virus-infected cells, the cleavage of p220 was
almost completed at 3 h postinfection (at 37 or 39°C). In
mutant-infected cells, only partial cleavage was seen at 6 h
postinfection; at its nonpermissive condition (39°C), 5NC-13
did not induce any cleavage of p220. As already seen with
host cell translational shutoff, an MOI effect was observed;
when cells were infected with increasing MOIs of 5NC-114,
a better, although still delayed, rate of cleavage of p220 was
observed.
Genetic analysis. As demonstrated above, all three mu-
tants we have examined here behaved similarly in the
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FIG. 3. RNA synthesis in virus-infected cells. Analysis was done by dot-blot as described in Materials and Methods. (A) 5NC-11 at 32.5
and 39.5°C. (B) 5NC-13 at 32.5 and 39.5°C. (C) 5NC-114 and 5NC-116 at 37°C. (D) Comparison of progeny yield (as determined by plaque
assay) and RNA synthesis for 5NC-114 with that of wild type.
infected cell, showing poor viral protein synthesis, absence
of host cell translational shutoff, and significant but delayed
viral RNA synthesis. We could not, however, conclude from
the experiments described so far what was the primary
defect created by the mutations. Genetic complementation is
a useful tool for identifying the effects of mutations in
viruses. In such an approach, cells are infected with one
virus alone or with two viruses together, and the yields of the
single and mixed infections are compared. A CI is calculated
from the ratio of these yields. If the growth of one of the
partners is enhanced in mixed infection, it is then known to
be defective in a function that can be provided in trans. The
existence of defective interfering particles in poliovirus (8)
demonstrates that the capsid proteins can be provided in
trans. It was also shown recently that two nonstructural
proteins, 2A and 3A, involved in translational shutoff and
RNA synthesis, respectively, carry out a trans rather than a
cis activity; other nonstructural functions (proteins 2B and
3D, 3NC region) seemingly act mainly in cis (1).
On the basis of these precedents, we analyzed the com-
plementation behavior of our mutants by testing their ability
to complement and be complemented by other well-defined
mutants. The ones we used were (Fig. 7) 1C-41, which maps
in the capsid region; 3D-56, which maps in the replicase
gene; 3NC-202, which maps in the 3NC region; and 2A-1 and
R2-A2-2, which map in the region encoding for the 2A
protein. The latter mutants, 2A-1 and R2-2A-2 (a gift from
V. R. Racaniello), both exhibit an inability to induce host
cell-specific translational shutoff, make a normal amount of
RNA, and produce in HeLa cells an early global transla-
tional shutoff, inhibiting both cellular and viral protein
synthesis (2; V. R. Racaniello, personal communication);
cleavage of p220 is also not induced in HeLa cells infected
with these mutants. To some extent, therefore, they produce
phenocopies of 5NC-13, 5NC-114, and 5NC-116; a major
difference is that the 5NC mutants do not induce a global
shutoff.
The results of the complementation experiments are best
considered in three groups.
First, 5NC-13, 5NC-114, and 5NC-116 did not comple-
ment each other (Table 2, lines 1 to 3). There was no
enhancement of the total progeny yield in mixedly infected
cells compared with that of singly infected cells. Thus, the
mutants fall in a single complementation group. When cells
were infected at 39°C with 5NC-13, a strongly temperature-
sensitive mutant, and 5NC-114, which does not exhibit the
same degree of temperature sensitivity, the growth of 5NC-
13 was enhanced but only to a level that was still a few fold
lower than the growth of 5NC-114. The growth of this latter
mutant was itself not enhanced. This suggested that these
mutants are defective to different degrees in the same
function, and that this function can be provided in trans; the
function made by the less-defective mutant was available for
use by both.
This analysis of one-way intragenic complementation was
confirmed by the second type of result. The 5NC mutants
were efficiently complemented by mutants 1C-41, 3D-56, and
3NC-202 (Table 2, lines 5 to 10), confirming the trans-acting
nature of their defect. The three mutants that complemented
the 5NC mutants grew very poorly if at all at 39°C, but they
dramatically increased the progeny yield of the 5NC mutants
in mixed infections. Therefore, they provided to the 5NC
mutants a function that the 5NC mutants could not perform.
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FIG. 4. Protein synthesis in virus-infected cells. Cells were pulsed at different times after infection with [35S]methionine, and extracts were
fractionated by electrophoresis through a 12.5% polyacrylamide gel which was then autoradiographed. Initial MOI was 10 PFU per cell unless
specified. (A) 5NC-13 at 39 and 32°C. (B) 5NC-114 and 5NC-116. (C) Effect of increasing MOIs of 5NC-114. Lanes: a, Mock-infected cells;
b, wild-type virus; c, 5NC-114; d, 5NC-116; e, 5NC-114 (MOI, 50 PFU per cell); f, 5NC-114 (MOI, 100 PFU per cell); g, 5NC-13.
As a control, 3NC-202 and 3D-56 did not detectably com-
plement each other (line 4).
Third and most importantly, mutants mapping in the 2A
region did not efficiently complement and were not effi-
ciently complemented by the 5NC mutants (Table 2, lines 12,
13, 15, and 16), even though the 2A function is an easily
complementable one (lines 11 and 14) (1). It appears that
mutations in the 5NC and the 2A region have deleterious
consequences for the same function. Again, there is some
unidirectional enhancement of 5NC-13 by 2A-1, presumably
by a mechanism similar to the one described earlier (see also
Discussion).
These results were confirmed by analyzing [15S]methio-
nine-labeled cytoplasmic extracts obtained from singly and
mixedly infected cells (Fig. 8). Compared with cells infected
with a single virus, cells coinfected with 3NC-202 and one of
the 5NC mutants showed an enhancement of host cell
translational inhibition and of virus-specific protein synthe-
sis (Fig. 8A, compare lanes 3, 6, 8, and 10 with lanes 7, 9,
and 11; best seen by looking at protein 3CD, shown by
arrow). On the other hand, in HeLa cells co-infected with
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FIG. 5. Analysis of virus-specific protein synthesis. Radiola-
beled cytoplasmic extracts were immunoprecipitated with a poly-
clonal antivirion antibody and analyzed by electrophoresis through
a 12.5% polyacrylamide gel. Lanes: v, [35S]methionine-radiolabeled
virion; a, mock-infected cells; b, wild-type virus; c, 5NC-114; d,
5NC-116; e, 5NC-13. The designation of the corresponding protein
is indicated on the right.
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FIG. 6. Fate of p220 in mock-, wild type-, and mutant-infected
cells. HeLa cells were infected at an MOI of 10 unless otherwise
specified. Cytoplasmic extracts harvested at 3 or 6 h postinfection
were electrophoresed through a 6.5% polyacrylamide gel, and the
resolved proteins were transferred to nitrocellulose. The filters were
probed with a polyclonal anti-p220 antiserum. Lanes: a, mock-
infected cells; b, wild-type virus; c, 5NC-114; d, 5NC-116; e,
5NC-114 (MOI, 50 PFU per cell); f, 5NC-114 (MOI, 100 PFU per
cell); g, 5NC-13. cl. pr., p220 cleavage products.
TABLE 2. Complementation experiments
Line Virus pair' CI at 3 h Pjb CI at 6 h PI
no.
1 5NC-13 + 5NC-114 1 (total) 1 (total)
1 (5NC-114) 1 (5NC-114)
15 (5NC-13) 6 (5NC-13)
2 5NC-114 + 5NC-116 1.2 (total 1 (total)
3 5NC-13 + 5NC-116 1 (total) 1.5 (total)
4 3NC-202 + 3D-56 1.3 1
5 5NC-13 + 3NC-202 120 140
6 5NC-114 + 3NC-202 150 43
7 5NC-13 + 3D-56 180 50
8 5NC-114 + 3D-56 40 20
9 5NC-13 + 1C-41 90 NDc
10 5NC-114 + 1C-41 40 ND
11 3NC-202 + 2A-ld 50 ND
12 5NC-13 + 2A-1d 1.2 (total) ND
20 (5NC-13)
13 5NC-114 + 2A-1d 2 (total) ND
14 3D-56 + R2-2A-2 40 ND
15 5NC-13 + R2-2A-2 2 (total) ND
16 5NC-114 + R2-2A-2 4 (total) ND
"The mutant complemented is in bold type.
b CI was calculated as described in Materials and Methods. PI, Postinfec-
tion.
' ND, Not determined.
d Done on CV1 cells.
2A-1 and one of the 5NC mutants, viral protein synthesis
was not enhanced, specific shutoff was not observed, and
instead a global inhibition of translation, both viral and
cellular, took place as in cells infected with 2A-1 alone (Fig.
8B, compare lane 3 with lanes 7, 8, and 9). This last point
makes a strong argument that the 5NC mutants are defective
in providing the 2A function; if it were not the case, then
they should have been able to prevent an event thought to be
a consequence of the absence of a functional 2A (24; see
Discussion).
DISCUSSION
We used a cDNA copy of poliovirus type 1 to generate 21
mutations in the 5NC region of the genome. RNA was made
from each of these clones, transfected into HeLa cells, and
scored for the ability to generate infectious virus particles.
Some mutations, distributed evenly over much of the 5NC
region, were lethal, meaning that no infectious virus was
recovered from transfected cells. Much of the 5NC region
appears therefore necessary to viral growth. Several muta-
tions were silent, including a deletion extending from nucle-
otide 630 to 723. Thus some regions can be altered without
significantly inhibiting viral growth, and one region is dis-
pensable for in vitro growth. Six mutations, targeting four
different sites, generated viruses with a recognizable pheno-
type; one mutant from each of these four sites was further
studied. Mutant 5NC-11, which has a 4-base insertion at
nucleotide 70, was primarily deficient in RNA synthesis;
work is in progress to define more precisely which step of
RNA synthesis is impaired. A mutant with a deletion of
nucleotide 10 was reported previously (20); it also showed a
major impairment of RNA synthesis, suggesting that the far
5' end of the genome is likely to be primarily involved in one
or more steps of RNA replication.
The three other mutants studied in some detail, 5NC-13,
5NC-114, and 5NC-116, mapping at positions 224, 270, and
392, respectively, showed similar behavior; they made very
little viral protein, they did not inhibit host cell translation,
and they synthesized a significant amount of viral RNA,
although with some delay compared with the wild type. This
defect in RNA synthesis was not reflected in any change in
the type of RNA made and was probably due to their
deficiency in protein synthesis.
To further analyze the nature of the three mutants defec-
tive in protein synthesis, we examined their complementa-
tion by other poliovirus mutants. Although pairwise infec-
tions among the 5NC mutants gave no overall yield
enhancement, they were efficiently complemented by all
tested mutants, except those with lesions in protein 2A. A
direct interpretation would be that the three 5NC mutants
lack a single function that can be complemented in trans by
all cistrons other than 2A. We will call the sequence within
which these mutants fall region P, to denote its role in
SNC-13,-114,-11 6
S'NC
IC.41 2A-1
P1
3D-56 3NC-202
I .1.,
P2 P3 3NC
FIG. 7. Mutants used in complementation experiments. The approximate genomic location of the mutants described in the text is shown.
R2-2A-2 contains a mutation mapping close to the one in 2A-1.
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FIG. 8. Complementation experiments. [35S]methionine-labeled
cytoplasmic extracts were prepared at 6 h postinfection from singly
and mixedly infected cells and analyzed as described in the text. The
mutants used are those shown in Fig. 7. (A) Complementation of
5NC mutants by a 3NC mutant. Lanes: 1, mock-infected cells; 2,
wild type; 3, 3NC-202; 4, 2A-1; 5, 3NC-202 + 2A-1; 6, 5NC-13; 7,
5NC-13 + 3NC-202; 8, 5NC-114;- 9, 5NC-114 + 3NC-202; 10,
5NC-116; 11, 5NC-116 + 3NC-202. The arrow shows protein 3CD.
(B) Absence of complementation of 5NC mutants by a 2A mutant.
Lanes: 1, mock-infected cells; 2, wild type; 3, 2A-1; 4, 5NC-13; 5,
5NC-114; 6, 5NC-116; 7, 5NC-13 + 2A-1; 8, 5NC-114 + 2A-1; 9,
5NC-116 + 2A-1.
protein synthesis. The lack of complementation by 2A
mutants highlights the role of region P because 2A is a
function easily complemented by all mutants other than the
SNC mutants (1). Knowing that region P is involved in
allowing translation of the viral RNA, it would appear that
the 5NC mutants make so little of protein 2A that it becomes
the limiting factor in the efficiency of viral infection. Thus,
all mutants that can provide any 2A, that is, all mutants but
those in 2A, can complement SNC mutants. The extra 2A in
co-infected cells inhibits host cell protein synthesis, a proc-
ess that SNC mutants are unable to carry out because they
make too little 2A by themselves.
We interpret the effect of providing 2A to region P mutants
as follows. The cellular ribosomes, no longer attracted to cell
mRNA when 2A function is provided, can better translate
poliovirus RNA with region P lesions, and thus the mutants
grow much more effectively. Because the region P mutants
make significant yields of RNA without complementation,
their particle yield is presumed to be a direct function of the
amount of capsid protein they make, and thus any increase
of viral protein synthesis causes a yield enhancement and is
scored as complementation. Only 2A mutants will not pro-
duce the effect. Even they complement a bit, presumably
because they make totally normal RNA yields and thus
provide a large pool of translatable RNA, although without
inhibition of host cell mRNA translation, this viral RNA has
a very limited translational potential.
The mutants in region P are not null mutants, they grow
and therefore exhibit partial function. The dead mutants in
region P, as represented in Fig. 2, we believe are true null
mutants, and we suggest that region P is absolutely required
for significant translation to occur.
Unitary function of region P and its role in neurovirulence.
The three mutants we found in region P clearly participate in
the same function; their physiology is almost indistinguish-
able, and they do not complement each other. They span
nucleotides 224 to 392. Consistent with this interpretation is
the result of substituting nucleotides 220 to 670 of poliovirus
with the corresponding region of coxsackie virus B3, another
picornavirus; the hybrid had a temperature-sensitive pheno-
type quite similar to that of our mutants (23).
The extent of region P is probably more than is evident
from our mutants. A mutant of Sabin 1 virus having a 4-base
insertion similar to the one present in 5NC-13 has been
reported previously (10); its biological properties were not
described, but the degree of similarity between the 5NC
regions of Mahoney and Sabin 1 strains suggests that it is
likely to present the same phenotype as our mutants. The
5NC regions of four partial revertants of this Sabin mutant
were sequenced. All had retained the original insertion;
second-site mutations were identified at nucleotides 186 and
525 in three as well as at nucleotides 186 and 480 in the
fourth. Although no mix-and-match experiment was done to
ascertain that the reversion was not the effect of mutations
elsewhere in the genome, this suggests that the functional
extent of region P may be at least from nucleotides 186 to
525. If the whole sequence contained within nucleotides 186
to 525 belongs to the same functional unit, it will include
nucleotides that have been found to be major determinants
of the attenuation of type 3 (27) and, to a lesser extent, of
type 1 (15) neurovirulence. This would suggest that attenu-
ation in vaccine strains might come from a specific inability
of motor neurons, as opposed to intestinal cells, to translate
the viral genonme. It has actually been shown that vaccine
strains translate more poorly than their wild-type parents, at
least in some in vitro systems (25). If such a model is true,
the 5NC region of poliovirus could be used as a target to
engineer live-virus vaccines with full immunogenic proper-
ties but better stability than the ones currently in use.
Function of region P. Our data does not directly suggest a
function for region P beyond the clear demonstration of
some role in viral protein synthesis. Using an in vitro
approach, Pelletier et al. (17) have obtained data also con-
sistent with an important role for this region in protein
synthesis. It is easiest to imagine a cis-acting role, for
instance providing what is usually a cap-dependent entry site
for ribosomes on the mRNA. Although all of our data is
consistent with such a cis-acting function, we also cannot
rule out a trans-acting process like ribosome modification.
The lack of complementation by 2A mutant argues against a
trans-active function but is not conclusive.
Viral protein needed for RNA synthesis. The data here
emphasize that very little viral protein is needed for viral
RNA synthesis to occur. The region P mutants, making very
little viral protein (perhaps 2% of normal), still make about
50% of the normal yield of RNA, albeit somewhat more
slowly than wild-type virus. Our previous analysis of mutant
2A-1 suggested that viral RNA synthesis requires little viral
protein (2), but the data here are even more compelling. This
conclusion is reasonable in that in virions each RNA mole-
cule is coated by 60 copies of the capsid proteins and
therefore RNA synthesis could require only 1/60 of the
amount of protein needed for maximal particle yield. Thus,
in adopting a genetic strategy using only one open reading
frame for translation of viral RNA, poliovirus never found
the need for the inevitable huge excess of RNA synthetic
proteins made to satisfy the need for capsid proteins.
Viral protein needed for host cell translational inhibition.
The results of our experiments show that more viral protein
is needed to inhibit host cell translation than to synthesize
viral RNA; the SNC mutants do not induce this inhibition
because they fail to produce enough protein 2A. This defect
in 2A is also underscored by the inability of the 5NC mutants
to prevent the early global inhibition of translation induced
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by 2A mutants in HeLa cells. There are suggestions that this
global inhibition is due to the phosphorylation of eucaryotic
initiation factor 2, a phenomenon observed with other vi-
ruses; the 2A protein might directly or indirectly prevent it
(24). Probably due to a delayed accumulation of viral RNA,
the 5NC mutants do not induce this global shutoff; however,
in mixed infection, when this global shutoff is induced by a
2A mutant, they are unable to prevent it.
5NC nucleotides in cellular mRNAs. The existence of a long
5' untranslated element in poliovirus mRNA raises the issue
of whether cellular mRNAs might not have such 5' structural
modules. They might also use them in initiating protein
synthesis. In favor of such a suggestion is the presence and
interspecies conservation of long 5' ends on certain cellular
mRNAs. If, however, such structural modules served in the
place of 5' caps as initiators of protein synthesis, then there
should be a class of cellular mRNAs that continues to be
translated in poliovirus-infected cells. Such a class has not
been detected, although one mRNA is less sensitive than
others (that for grp78; P. Sarnow and D. Baltimore, unpub-
lished data) and rare mRNAs might not have been evident.
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